Deep learning enabled medulloblastoma prognosis and biomarker discovery

We requested CBTN specimens to complete our research program, mostly for test the generalization ability of trained deep learning model. Currently we do not have enough medulloblastoma pathology slides for external test, which makes it difficult to obtain credible conclusions. we need to use CBTN pathology whole slide images for deep learning to find out the available feature information to achieve our goal.